|
PF-37084 |
THERAFLU 7.5 mg Laminas Dispersables Orales |
2011-03-08 |
|
Novartis Consumer Health, Inc. |
Estados Unidos de América
|
Novartis Farmacéutica, Sociedad Anónima (América Central) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-37095 |
THERAFLU 15 mg Laminas Dispersables Orales |
2011-03-10 |
|
Novartis Consumer Health, Inc. |
Estados Unidos de América
|
Novartis Farmacéutica, Sociedad Anónima (América Central) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-37096 |
THERAFLU 12.5 mg Laminas Dispersables Orales |
2011-03-10 |
|
Novartis Consumer Health, Inc. |
Estados Unidos de América
|
Novartis Farmacéutica, Sociedad Anónima (América Central) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFN-48766 |
BOWEFLOR Cápsulas |
2023-07-04 |
|
ADM Protexin Limited |
Reino Unido
|
Leterago |
Codalo |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFN-48767 |
BOWEFLOR Polvo para suspensión oral |
2023-07-04 |
|
ADM Protexin Limited |
Reino Unido
|
Leterago |
Codalo |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFD-57472 |
MULTIFLORA ADVANCE Cápsulas |
2024-11-12 |
|
ADM Protexin Limited |
Reino Unido
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFD-46506 |
MULTIFLORA Comprimidos masticables |
2026-10-08 |
|
ADM Protexin Limited |
Reino Unido
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFD-47123 |
MULTIFLORA PLUS Cápsulas |
2027-03-22 |
|
ADM Protexin Limited |
Reino Unido
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFN-46501 |
MULTIFLORA Polvo para Suspensión Oral |
2026-10-22 |
|
ADM Protexin Limited |
Reino Unido
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-58148 |
ZOLIDONE 2 mg/mL Solución Inyectable |
2025-04-17 |
|
ADS Pharma S.A.S. |
Colombia
|
Futura Farma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|